An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest. The ...

A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make medical imaging of breast cancer tumors quicker and more accurate, and ...

Researchers in the U.S. and U.K. have developed what they say is a more accurate way to scan for tuberculosis (TB) using positron emission tomography (PET) to detect the causative Mycobacterium ...

Prototype sensor with scintillating fibre inserted partially into an artificial vein. (Courtesy: Josh Knowland) Cancerous cells have a higher metabolic activity than normal healthy cells, and ...

A new radiotracer has been developed to diagnose prostate cancer. Prostate cancer is the fifth leading cause of death worldwide and is especially difficult to diagnose. While prostate cancer is ...

Scientists have developed a new radiotracer (called [18F]4-FDF) that can map how cells use fructose for energy. The vast majority of positron emission tomography (PET) imaging systems map out how the ...

Please provide your email address to receive an email when new articles are posted on . PET with the radiotracer 18F flurpiridaz had better sensitivity and similar specificity vs. SPECT in patients ...

A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make medical imaging of breast cancer tumors quicker and more accurate, and ...

Reston, VA—A new PET radiotracer enables same-day imaging of the important gastrointestinal cancer biomarker known as Claudin18.2 (CLDN18.2). Uptake of the radiotracer, 68 Ga-NC-BCH, was found to ...

Researchers have developed a radiotracer that can detect fructose metabolism, paving the way for a clinically viable tool for the earlier detection of multiple conditions. Fructolysis, the action of ...

Reston, VA (Embargoed until 4:30 p.m. EDT, Saturday, June 12, 2021)--Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify ...